Channing Capital Management, LLC Bristol Myers Squibb CO Transaction History

Channing Capital Management, LLC

$3.54 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $2,430 - $1.44 Million	18,693 Added 14.77%	145,217 $10.3 Million
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $1.91 Million - $2.11 Million	-26,366 Reduced 17.25%	126,524 $9.74 Million
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $1.4 Million - $1.68 Million	-22,812 Reduced 12.98%	152,890 $11.2 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $8,527 - $9,940	159 Added 0.09%	175,702 $11 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $590,279 - $691,436	9,976 Added 6.03%	175,543 $10.4 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $2.35 Million - $2.56 Million	38,011 Added 29.8%	165,567 $11.1 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $628,885 - $707,310	10,598 Added 9.06%	127,556 $8.05 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $1.78 Million - $2.02 Million	30,907 Added 35.92%	116,958 $7.26 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $225,757 - $250,168	-3,931 Reduced 4.37%	86,051 $5.19 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $602,965 - $704,925	-10,999 Reduced 10.89%	89,982 $5.29 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $1.44 Million - $2.1 Million	-31,095 Reduced 23.54%	100,981 $5.63 Million
Q4 2019 Feb 12, 2020	SELL	$49.21 - $64.19 $2.77 Million - $3.62 Million	-56,358 Reduced 29.91%	132,076 $8.48 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $449,598 - $533,063	10,512 Added 5.91%	188,434 $9.56 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $1.74 Million - $1.92 Million	38,938 Added 28.02%	177,922 $8.07 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $891,796 - $1.06 Million	-19,765 Reduced 12.45%	138,984 $6.63 Million
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $323,327 - $419,278	-6,631 Reduced 4.01%	158,749 $8.25 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $102,984 - $116,158	1,866 Added 1.14%	165,380 $10.3 Million
Q2 2018 Jul 20, 2018	BUY	$50.53 - $62.98 $3.93 Million - $4.89 Million	77,691 Added 90.52%	163,514 $9.05 Million
Q1 2018 Apr 24, 2018	BUY	$59.92 - $68.98 $7,310 - $8,415	122 Added 0.14%	85,823 $5.43 Million
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $4.73 Million - $5.46 Million	85,701	85,701 $5.46 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Channing Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Channing Capital Management, LLC with notifications on news.

Account